ReP USP - Resultado da busca

Artigo de periodico
Influence of polymorphisms in IRS1, IRS2, MC3R, and MC4R on metabolic and inflammatory status and food intake in Brazilian adults: An exploratory pilot study (2023)
Fajardo, Cristina Moreno ; Cerda, Alvaro ; Bortolin, Raul Hernandes ; Oliveira, Raquel de; Stefani, Tamires Invencioni Moraes; Santos, Marina Aparecida dos; Braga, Aécio Assunção; Dorea, Egídio Lima; Bernik, Marcia Martins Silveira; Bastos, Gisele Medeiros; Sampaio, Marcelo Ferraz; Damasceno, Nágila Raquel Teixeira; Verlengia, Rozangela; Oliveira, Maria Rita Marques de; Hirata, Mario Hiroyuki ; Hirata, Rosario Dominguez Crespo
Fonte: Nutrition Research. Unidades: FCF, HU, FSP
Assuntos: POLIMORFISMO, OBESIDADE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FAJARDO, Cristina Moreno et al. Influence of polymorphisms in IRS1, IRS2, MC3R, and MC4R on metabolic and inflammatory status and food intake in Brazilian adults: An exploratory pilot study. Nutrition Research, v. 119, p. 21-32, 2023Tradução . . Disponível em: https://dx.doi.org/10.1016/j.nutres.2023.08.008. Acesso em: 03 jul. 2024.
APA
Fajardo, C. M., Cerda, A., Bortolin, R. H., Oliveira, R. de, Stefani, T. I. M., Santos, M. A. dos, et al. (2023). Influence of polymorphisms in IRS1, IRS2, MC3R, and MC4R on metabolic and inflammatory status and food intake in Brazilian adults: An exploratory pilot study. Nutrition Research, 119, 21-32. doi:10.1016/j.nutres.2023.08.008
NLM
Fajardo CM, Cerda A, Bortolin RH, Oliveira R de, Stefani TIM, Santos MA dos, Braga AA, Dorea EL, Bernik MMS, Bastos GM, Sampaio MF, Damasceno NRT, Verlengia R, Oliveira MRM de, Hirata MH, Hirata RDC. Influence of polymorphisms in IRS1, IRS2, MC3R, and MC4R on metabolic and inflammatory status and food intake in Brazilian adults: An exploratory pilot study [Internet]. Nutrition Research. 2023 ; 119 21-32.[citado 2024 jul. 03 ] Available from: https://dx.doi.org/10.1016/j.nutres.2023.08.008
Vancouver
Fajardo CM, Cerda A, Bortolin RH, Oliveira R de, Stefani TIM, Santos MA dos, Braga AA, Dorea EL, Bernik MMS, Bastos GM, Sampaio MF, Damasceno NRT, Verlengia R, Oliveira MRM de, Hirata MH, Hirata RDC. Influence of polymorphisms in IRS1, IRS2, MC3R, and MC4R on metabolic and inflammatory status and food intake in Brazilian adults: An exploratory pilot study [Internet]. Nutrition Research. 2023 ; 119 21-32.[citado 2024 jul. 03 ] Available from: https://dx.doi.org/10.1016/j.nutres.2023.08.008
Artigo de periodico
In silico analysis of upstream variants in Brazilian patients with Familial hypercholesterolemia (2023)
Araújo, Jéssica Nayara Góes de ; Oliveira, Victor Fernandes de ; Borges, Jéssica Bassani ; Hernandez, Carolina Dagli ; Marçal, Elisangela da Silva Rodrigues; Freitas, Renata Caroline Costa de ; Bastos, Gisele Medeiros ; Gonçalves, Rodrigo Marques; Faludi, André Arpad; Jannes, Cinthia Elim; Pereira, Alexandre da Costa ; Hirata, Rosario Dominguez Crespo ; Hirata, Mario Hiroyuki ; Luchessi, André Ducati ; Silbiger, Vivian Nogueira
Fonte: Gene. Unidades: FM, FCF
Assuntos: HIPERCOLESTEROLEMIA, GENOMAS, BIOINFORMÁTICA, NUCLEOTÍDEOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ARAÚJO, Jéssica Nayara Góes de et al. In silico analysis of upstream variants in Brazilian patients with Familial hypercholesterolemia. Gene, v. 849, p. 1-7 art. 146908, 2023Tradução . . Disponível em: https://doi.org/10.1016/j.gene.2022.146908. Acesso em: 03 jul. 2024.
APA
Araújo, J. N. G. de, Oliveira, V. F. de, Borges, J. B., Hernandez, C. D., Marçal, E. da S. R., Freitas, R. C. C. de, et al. (2023). In silico analysis of upstream variants in Brazilian patients with Familial hypercholesterolemia. Gene, 849, 1-7 art. 146908. doi:10.1016/j.gene.2022.146908
NLM
Araújo JNG de, Oliveira VF de, Borges JB, Hernandez CD, Marçal E da SR, Freitas RCC de, Bastos GM, Gonçalves RM, Faludi AA, Jannes CE, Pereira A da C, Hirata RDC, Hirata MH, Luchessi AD, Silbiger VN. In silico analysis of upstream variants in Brazilian patients with Familial hypercholesterolemia [Internet]. Gene. 2023 ; 849 1-7 art. 146908.[citado 2024 jul. 03 ] Available from: https://doi.org/10.1016/j.gene.2022.146908
Vancouver
Araújo JNG de, Oliveira VF de, Borges JB, Hernandez CD, Marçal E da SR, Freitas RCC de, Bastos GM, Gonçalves RM, Faludi AA, Jannes CE, Pereira A da C, Hirata RDC, Hirata MH, Luchessi AD, Silbiger VN. In silico analysis of upstream variants in Brazilian patients with Familial hypercholesterolemia [Internet]. Gene. 2023 ; 849 1-7 art. 146908.[citado 2024 jul. 03 ] Available from: https://doi.org/10.1016/j.gene.2022.146908
Artigo de periodico
The let-7b-5p, miR-326, and miR-125a-3p are associated with left ventricular systolic dysfunction in post-myocardial infarction (2023)
Komatsu, Raquel Costa Silva Dantas ; Cruz, Marina Sampaio; Freire, Paula Paccielli ; Diniz, Rosiane Viana Zuza; Bortolin, Raul Hernandes ; Marques, Otavio Cabral ; Souza, Kamilla Batista da Silva; Hirata, Mario Hiroyuki ; Hirata, Rosario Dominguez Crespo ; Reis, Bruna Zavarize ; Jurisica, Igor ; Silbiger, Vivian Nogueira ; Luchessi, Andre Ducati
Fonte: Frontiers in Cardiovascular Medicine. Unidades: FM, FCF, ICB
Assuntos: INFARTO DO MIOCÁRDIO, MICRORNAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
KOMATSU, Raquel Costa Silva Dantas et al. The let-7b-5p, miR-326, and miR-125a-3p are associated with left ventricular systolic dysfunction in post-myocardial infarction. Frontiers in Cardiovascular Medicine, v. 10, p. 1-11 art. 1151855, 2023Tradução . . Disponível em: https://dx.doi.org/10.3389/fcvm.2023.1151855. Acesso em: 03 jul. 2024.
APA
Komatsu, R. C. S. D., Cruz, M. S., Freire, P. P., Diniz, R. V. Z., Bortolin, R. H., Marques, O. C., et al. (2023). The let-7b-5p, miR-326, and miR-125a-3p are associated with left ventricular systolic dysfunction in post-myocardial infarction. Frontiers in Cardiovascular Medicine, 10, 1-11 art. 1151855. doi:10.3389/fcvm.2023.1151855
NLM
Komatsu RCSD, Cruz MS, Freire PP, Diniz RVZ, Bortolin RH, Marques OC, Souza KB da S, Hirata MH, Hirata RDC, Reis BZ, Jurisica I, Silbiger VN, Luchessi AD. The let-7b-5p, miR-326, and miR-125a-3p are associated with left ventricular systolic dysfunction in post-myocardial infarction [Internet]. Frontiers in Cardiovascular Medicine. 2023 ; 10 1-11 art. 1151855.[citado 2024 jul. 03 ] Available from: https://dx.doi.org/10.3389/fcvm.2023.1151855
Vancouver
Komatsu RCSD, Cruz MS, Freire PP, Diniz RVZ, Bortolin RH, Marques OC, Souza KB da S, Hirata MH, Hirata RDC, Reis BZ, Jurisica I, Silbiger VN, Luchessi AD. The let-7b-5p, miR-326, and miR-125a-3p are associated with left ventricular systolic dysfunction in post-myocardial infarction [Internet]. Frontiers in Cardiovascular Medicine. 2023 ; 10 1-11 art. 1151855.[citado 2024 jul. 03 ] Available from: https://dx.doi.org/10.3389/fcvm.2023.1151855
Artigo de periodico
Lipidomic analysis identified potential predictive biomarkers of statin response in subjects with Familial hypercholesterolemia (2023)
Cerda, Alvaro; Bortolin, Raul Hernandes ; Yoshinaga, Marcos Yukio ; Freitas, Renata Caroline Costa de ; Hernandez, Carolina Dagli; Borges, Jessica Bassani; Oliveira, Victor Fernandes de ; Gonçalves, Rodrigo Marques; Faludi, André Arpad; Bastos, Gisele Medeiros ; Hirata, Rosario Dominguez Crespo ; Hirata, Mario Hiroyuki
Fonte: Chemistry and Physics of Lipids. Unidades: FCF, ICB
Assuntos: BIOMARCADORES, ESTATINAS, HIPERCOLESTEROLEMIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CERDA, Alvaro et al. Lipidomic analysis identified potential predictive biomarkers of statin response in subjects with Familial hypercholesterolemia. Chemistry and Physics of Lipids, v. 257, p. 1-9 art. 105348, 2023Tradução . . Disponível em: https://dx.doi.org/10.1016/j.chemphyslip.2023.105348. Acesso em: 03 jul. 2024.
APA
Cerda, A., Bortolin, R. H., Yoshinaga, M. Y., Freitas, R. C. C. de, Hernandez, C. D., Borges, J. B., et al. (2023). Lipidomic analysis identified potential predictive biomarkers of statin response in subjects with Familial hypercholesterolemia. Chemistry and Physics of Lipids, 257, 1-9 art. 105348. doi:10.1016/j.chemphyslip.2023.105348
NLM
Cerda A, Bortolin RH, Yoshinaga MY, Freitas RCC de, Hernandez CD, Borges JB, Oliveira VF de, Gonçalves RM, Faludi AA, Bastos GM, Hirata RDC, Hirata MH. Lipidomic analysis identified potential predictive biomarkers of statin response in subjects with Familial hypercholesterolemia [Internet]. Chemistry and Physics of Lipids. 2023 ; 257 1-9 art. 105348.[citado 2024 jul. 03 ] Available from: https://dx.doi.org/10.1016/j.chemphyslip.2023.105348
Vancouver
Cerda A, Bortolin RH, Yoshinaga MY, Freitas RCC de, Hernandez CD, Borges JB, Oliveira VF de, Gonçalves RM, Faludi AA, Bastos GM, Hirata RDC, Hirata MH. Lipidomic analysis identified potential predictive biomarkers of statin response in subjects with Familial hypercholesterolemia [Internet]. Chemistry and Physics of Lipids. 2023 ; 257 1-9 art. 105348.[citado 2024 jul. 03 ] Available from: https://dx.doi.org/10.1016/j.chemphyslip.2023.105348
Artigo de periodico
LDLR and PCSK9 3´UTR variants and their putative effects on microRNA molecular interactions in familial hypercholesterolemia: a computational approach (2023)
Freitas, Renata Caroline Costa de ; Bortolin, Raul Hernandes ; Borges, Jéssica Bassani ; Oliveira, Victor Fernandes de; Hernandez, Carolina Dagli ; Marçal, Elisangela da Silva Rodrigues; Bastos, Gisele Medeiros ; Gonçalves, Rodrigo Marques; Faludi, André Arpad; Silbiger, Vivian Nogueira ; Luchessi, Andre Ducati ; Hirata, Rosario Dominguez Crespo ; Hirata, Mario Hiroyuki
Fonte: Molecular Biology Reports. Unidades: IDPC, FCF
Assuntos: MICRORNAS, HIPERCOLESTEROLEMIA, LIPOPROTEÍNAS LDL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FREITAS, Renata Caroline Costa de et al. LDLR and PCSK9 3´UTR variants and their putative effects on microRNA molecular interactions in familial hypercholesterolemia: a computational approach. Molecular Biology Reports, v. 50, n. 11, p. 9165-9177, 2023Tradução . . Disponível em: https://dx.doi.org/10.1007/s11033-023-08784-9. Acesso em: 03 jul. 2024.
APA
Freitas, R. C. C. de, Bortolin, R. H., Borges, J. B., Oliveira, V. F. de, Hernandez, C. D., Marçal, E. da S. R., et al. (2023). LDLR and PCSK9 3´UTR variants and their putative effects on microRNA molecular interactions in familial hypercholesterolemia: a computational approach. Molecular Biology Reports, 50( 11), 9165-9177. doi:10.1007/s11033-023-08784-9
NLM
Freitas RCC de, Bortolin RH, Borges JB, Oliveira VF de, Hernandez CD, Marçal E da SR, Bastos GM, Gonçalves RM, Faludi AA, Silbiger VN, Luchessi AD, Hirata RDC, Hirata MH. LDLR and PCSK9 3´UTR variants and their putative effects on microRNA molecular interactions in familial hypercholesterolemia: a computational approach [Internet]. Molecular Biology Reports. 2023 ; 50( 11): 9165-9177.[citado 2024 jul. 03 ] Available from: https://dx.doi.org/10.1007/s11033-023-08784-9
Vancouver
Freitas RCC de, Bortolin RH, Borges JB, Oliveira VF de, Hernandez CD, Marçal E da SR, Bastos GM, Gonçalves RM, Faludi AA, Silbiger VN, Luchessi AD, Hirata RDC, Hirata MH. LDLR and PCSK9 3´UTR variants and their putative effects on microRNA molecular interactions in familial hypercholesterolemia: a computational approach [Internet]. Molecular Biology Reports. 2023 ; 50( 11): 9165-9177.[citado 2024 jul. 03 ] Available from: https://dx.doi.org/10.1007/s11033-023-08784-9
Artigo de periodico
Influence of antidepressant drugs on DNA methylation of ion channels genes in blood cells of psychiatric patients (2022)
Nascimento, Larissa Vilela ; Lotufo Neto, Francisco ; Moreira, Dalmo Antonio Ribeiro ; Cerutti, Virginia Braga; Thurow, Helena Strelow ; Bastos, Gisele Medeiros ; Ferreira, Eric Batista ; Hirata, Rosario Dominguez Crespo ; Hirata, Mario Hiroyuki
Fonte: Epigenomics. Unidades: FM, IDPC, FCF
Assuntos: METILAÇÃO DE DNA, ANTIDEPRESSIVOS, ARRITMIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
NASCIMENTO, Larissa Vilela et al. Influence of antidepressant drugs on DNA methylation of ion channels genes in blood cells of psychiatric patients. Epigenomics, v. 14, n. 14, p. 851-864, 2022Tradução . . Disponível em: https://doi.org/10.2217/epi-2022-0089. Acesso em: 03 jul. 2024.
APA
Nascimento, L. V., Lotufo Neto, F., Moreira, D. A. R., Cerutti, V. B., Thurow, H. S., Bastos, G. M., et al. (2022). Influence of antidepressant drugs on DNA methylation of ion channels genes in blood cells of psychiatric patients. Epigenomics, 14( 14), 851-864. doi:10.2217/epi-2022-0089
NLM
Nascimento LV, Lotufo Neto F, Moreira DAR, Cerutti VB, Thurow HS, Bastos GM, Ferreira EB, Hirata RDC, Hirata MH. Influence of antidepressant drugs on DNA methylation of ion channels genes in blood cells of psychiatric patients [Internet]. Epigenomics. 2022 ; 14( 14): 851-864.[citado 2024 jul. 03 ] Available from: https://doi.org/10.2217/epi-2022-0089
Vancouver
Nascimento LV, Lotufo Neto F, Moreira DAR, Cerutti VB, Thurow HS, Bastos GM, Ferreira EB, Hirata RDC, Hirata MH. Influence of antidepressant drugs on DNA methylation of ion channels genes in blood cells of psychiatric patients [Internet]. Epigenomics. 2022 ; 14( 14): 851-864.[citado 2024 jul. 03 ] Available from: https://doi.org/10.2217/epi-2022-0089
Artigo de periodico
Pharmacogenomics of statins: lipid response and other outcomes in Brazilian cohorts (2022)
Hernandez, Carolina Dagli ; Zhou, Yitian; Lauschke, Volker Martin; Genvigir, Fabiana Dalla Vecchia ; Hirata, Thiago Dominguez Crespo ; Hirata, Mario Hiroyuki ; Hirata, Rosario Dominguez Crespo
Fonte: Pharmacological Reports. Unidade: FCF
Assuntos: ESTATINAS, FARMACOGENÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
HERNANDEZ, Carolina Dagli et al. Pharmacogenomics of statins: lipid response and other outcomes in Brazilian cohorts. Pharmacological Reports, v. 74, p. 47–66, 2022Tradução . . Disponível em: https://doi.org/10.1007/s43440-021-00319-y. Acesso em: 03 jul. 2024.
APA
Hernandez, C. D., Zhou, Y., Lauschke, V. M., Genvigir, F. D. V., Hirata, T. D. C., Hirata, M. H., & Hirata, R. D. C. (2022). Pharmacogenomics of statins: lipid response and other outcomes in Brazilian cohorts. Pharmacological Reports, 74, 47–66. doi:10.1007/s43440-021-00319-y
NLM
Hernandez CD, Zhou Y, Lauschke VM, Genvigir FDV, Hirata TDC, Hirata MH, Hirata RDC. Pharmacogenomics of statins: lipid response and other outcomes in Brazilian cohorts [Internet]. Pharmacological Reports. 2022 ; 74 47–66.[citado 2024 jul. 03 ] Available from: https://doi.org/10.1007/s43440-021-00319-y
Vancouver
Hernandez CD, Zhou Y, Lauschke VM, Genvigir FDV, Hirata TDC, Hirata MH, Hirata RDC. Pharmacogenomics of statins: lipid response and other outcomes in Brazilian cohorts [Internet]. Pharmacological Reports. 2022 ; 74 47–66.[citado 2024 jul. 03 ] Available from: https://doi.org/10.1007/s43440-021-00319-y
Artigo de periodico
TREML4 polymorphisms increase the mRNA in blood leukocytes in the progression of atherosclerosis (2022)
Duarte, Victor Hugo Rezende ; Cruz, Marina Sampaio; Bertolami, Adriana; Hirata, Mario Hiroyuki ; Hirata, Rosario Dominguez Crespo ; Luchessi, André Ducati ; Silbiger, Vivian Nogueira
Fonte: Scientifc Reports. Unidade: FCF
Assuntos: LEUCÓCITOS, ARTERIOSCLEROSE, BIOMARCADORES, CARDIOLOGIA, BIOLOGIA MOLECULAR, GENÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DUARTE, Victor Hugo Rezende et al. TREML4 polymorphisms increase the mRNA in blood leukocytes in the progression of atherosclerosis. Scientifc Reports, v. 12, p. 1-9 art. 18612, 2022Tradução . . Disponível em: https://doi.org/10.1038/s41598-022-22040-3. Acesso em: 03 jul. 2024.
APA
Duarte, V. H. R., Cruz, M. S., Bertolami, A., Hirata, M. H., Hirata, R. D. C., Luchessi, A. D., & Silbiger, V. N. (2022). TREML4 polymorphisms increase the mRNA in blood leukocytes in the progression of atherosclerosis. Scientifc Reports, 12, 1-9 art. 18612. doi:10.1038/s41598-022-22040-3
NLM
Duarte VHR, Cruz MS, Bertolami A, Hirata MH, Hirata RDC, Luchessi AD, Silbiger VN. TREML4 polymorphisms increase the mRNA in blood leukocytes in the progression of atherosclerosis [Internet]. Scientifc Reports. 2022 ; 12 1-9 art. 18612.[citado 2024 jul. 03 ] Available from: https://doi.org/10.1038/s41598-022-22040-3
Vancouver
Duarte VHR, Cruz MS, Bertolami A, Hirata MH, Hirata RDC, Luchessi AD, Silbiger VN. TREML4 polymorphisms increase the mRNA in blood leukocytes in the progression of atherosclerosis [Internet]. Scientifc Reports. 2022 ; 12 1-9 art. 18612.[citado 2024 jul. 03 ] Available from: https://doi.org/10.1038/s41598-022-22040-3
Artigo de periodico
Pharmacogenomics of mycophenolic acid in kidney transplantation: Contribution of immune response-related genes (2022)
Hirata, Rosario Dominguez Crespo ; Genvigir, Fabiana Dalla Vecchia ; Hirata, Thiago Dominguez Crespo ; Cerda, Alvaro ; Hirata, Mario Hiroyuki
Fonte: Brazilian Journal of Pharmaceutical Sciences. Unidade: FCF
Assuntos: TRANSPLANTE DE RIM, FÁRMACOS IMUNOSSUPRESSORES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
HIRATA, Rosario Dominguez Crespo et al. Pharmacogenomics of mycophenolic acid in kidney transplantation: Contribution of immune response-related genes. Brazilian Journal of Pharmaceutical Sciences, v. 58, p. 1-22 art. e201188, 2022Tradução . . Disponível em: https://doi.org/10.1590/s2175-97902022e201188. Acesso em: 03 jul. 2024.
APA
Hirata, R. D. C., Genvigir, F. D. V., Hirata, T. D. C., Cerda, A., & Hirata, M. H. (2022). Pharmacogenomics of mycophenolic acid in kidney transplantation: Contribution of immune response-related genes. Brazilian Journal of Pharmaceutical Sciences, 58, 1-22 art. e201188. doi:10.1590/s2175-97902022e201188
NLM
Hirata RDC, Genvigir FDV, Hirata TDC, Cerda A, Hirata MH. Pharmacogenomics of mycophenolic acid in kidney transplantation: Contribution of immune response-related genes [Internet]. Brazilian Journal of Pharmaceutical Sciences. 2022 ; 58 1-22 art. e201188.[citado 2024 jul. 03 ] Available from: https://doi.org/10.1590/s2175-97902022e201188
Vancouver
Hirata RDC, Genvigir FDV, Hirata TDC, Cerda A, Hirata MH. Pharmacogenomics of mycophenolic acid in kidney transplantation: Contribution of immune response-related genes [Internet]. Brazilian Journal of Pharmaceutical Sciences. 2022 ; 58 1-22 art. e201188.[citado 2024 jul. 03 ] Available from: https://doi.org/10.1590/s2175-97902022e201188
Artigo de periodico
Toll-like receptor inflammatory cascade and the development of diabetic kidney disease in children and adolescents with type 1 diabetes (2022)
Melo, Thamara R. De; Souza, Karla Simone Costa de ; Ururahy, Marcela Abbott Galvão ; Bortolin, Raul Hernandes ; Bezerra, João F ; Galvão, Marcos Felipe de Oliveira ; Hirata, Rosario Dominguez Crespo ; Hirata, Mario Hiroyuki ; Arrais, Ricardo Fernando ; Almeida, Maria Das Graças ; Rezende, Adriana Augusto ; Silbiger, Vivian Nogueira
Fonte: Journal of Paediatrics and Child Health. Unidade: FCF
Assuntos: NEFROPATIAS, DIABETES MELLITUS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MELO, Thamara R. De et al. Toll-like receptor inflammatory cascade and the development of diabetic kidney disease in children and adolescents with type 1 diabetes. Journal of Paediatrics and Child Health, v. 58, n. 6, p. 996-1000, 2022Tradução . . Disponível em: https://doi.org/10.1111/jpc.15884. Acesso em: 03 jul. 2024.
APA
Melo, T. R. D., Souza, K. S. C. de, Ururahy, M. A. G., Bortolin, R. H., Bezerra, J. F., Galvão, M. F. de O., et al. (2022). Toll-like receptor inflammatory cascade and the development of diabetic kidney disease in children and adolescents with type 1 diabetes. Journal of Paediatrics and Child Health, 58( 6), 996-1000. doi:10.1111/jpc.15884
NLM
Melo TRD, Souza KSC de, Ururahy MAG, Bortolin RH, Bezerra JF, Galvão MF de O, Hirata RDC, Hirata MH, Arrais RF, Almeida MDG, Rezende AA, Silbiger VN. Toll-like receptor inflammatory cascade and the development of diabetic kidney disease in children and adolescents with type 1 diabetes [Internet]. Journal of Paediatrics and Child Health. 2022 ; 58( 6): 996-1000.[citado 2024 jul. 03 ] Available from: https://doi.org/10.1111/jpc.15884
Vancouver
Melo TRD, Souza KSC de, Ururahy MAG, Bortolin RH, Bezerra JF, Galvão MF de O, Hirata RDC, Hirata MH, Arrais RF, Almeida MDG, Rezende AA, Silbiger VN. Toll-like receptor inflammatory cascade and the development of diabetic kidney disease in children and adolescents with type 1 diabetes [Internet]. Journal of Paediatrics and Child Health. 2022 ; 58( 6): 996-1000.[citado 2024 jul. 03 ] Available from: https://doi.org/10.1111/jpc.15884
Artigo de periodico
Cardiovascular pharmacogenomics: an update on clinical studies of antithrombotic drugs in Brazilian patients (2021)
Hirata, Thiago Dominguez Crespo ; Hernandez, Carolina Dagli ; Genvigir, Fabiana Dalla Vecchia ; Lauschke, Volker Martin ; Zhou, Yitian ; Hirata, Mario Hiroyuki ; Hirata, Rosario Dominguez Crespo
Fonte: Molecular Diagnosis and Therapy. Unidade: FCF
Assuntos: ANTICOAGULANTES, DOENÇAS CARDIOVASCULARES, TROMBOSE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
HIRATA, Thiago Dominguez Crespo et al. Cardiovascular pharmacogenomics: an update on clinical studies of antithrombotic drugs in Brazilian patients. Molecular Diagnosis and Therapy, v. 25, p. 735–755, 2021Tradução . . Disponível em: https://doi.org/10.1007/s40291-021-00549-z. Acesso em: 03 jul. 2024.
APA
Hirata, T. D. C., Hernandez, C. D., Genvigir, F. D. V., Lauschke, V. M., Zhou, Y., Hirata, M. H., & Hirata, R. D. C. (2021). Cardiovascular pharmacogenomics: an update on clinical studies of antithrombotic drugs in Brazilian patients. Molecular Diagnosis and Therapy, 25, 735–755. doi:10.1007/s40291-021-00549-z
NLM
Hirata TDC, Hernandez CD, Genvigir FDV, Lauschke VM, Zhou Y, Hirata MH, Hirata RDC. Cardiovascular pharmacogenomics: an update on clinical studies of antithrombotic drugs in Brazilian patients [Internet]. Molecular Diagnosis and Therapy. 2021 ; 25 735–755.[citado 2024 jul. 03 ] Available from: https://doi.org/10.1007/s40291-021-00549-z
Vancouver
Hirata TDC, Hernandez CD, Genvigir FDV, Lauschke VM, Zhou Y, Hirata MH, Hirata RDC. Cardiovascular pharmacogenomics: an update on clinical studies of antithrombotic drugs in Brazilian patients [Internet]. Molecular Diagnosis and Therapy. 2021 ; 25 735–755.[citado 2024 jul. 03 ] Available from: https://doi.org/10.1007/s40291-021-00549-z
Artigo de periodico
Peripheral blood mirome identified miR-155 as potential biomarker of MetS and cardiometabolic risk in obese patients (2021)
Cerda, Alvaro ; Amaral, Adonai Aralim; Oliveira, Raquel de; Moraes, Tamiris Invencioni; Braga, Aécio Assunção; Saldarriaga, Magda Elizabeth Graciano; Fajardo, Cristina Moreno ; Hirata, Thiago Dominguez Crespo ; Bonezi, Vivian; Salazar, Antony Brayan Campos ; Dórea, Egidio Lima; Bernik, Marcia Martins Silveira; Hirata, Mario Hiroyuki ; Hirata, Rosario Dominguez Crespo
Fonte: International of Journal Molecular Sciences. Unidades: FCF, HU
Assuntos: OBESIDADE, MICRORNAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CERDA, Alvaro et al. Peripheral blood mirome identified miR-155 as potential biomarker of MetS and cardiometabolic risk in obese patients. International of Journal Molecular Sciences, v. 22, p. 1-14 art. 1468, 2021Tradução . . Disponível em: https://doi.org/10.3390/ijms22031468. Acesso em: 03 jul. 2024.
APA
Cerda, A., Amaral, A. A., Oliveira, R. de, Moraes, T. I., Braga, A. A., Saldarriaga, M. E. G., et al. (2021). Peripheral blood mirome identified miR-155 as potential biomarker of MetS and cardiometabolic risk in obese patients. International of Journal Molecular Sciences, 22, 1-14 art. 1468. doi:10.3390/ijms22031468
NLM
Cerda A, Amaral AA, Oliveira R de, Moraes TI, Braga AA, Saldarriaga MEG, Fajardo CM, Hirata TDC, Bonezi V, Salazar ABC, Dórea EL, Bernik MMS, Hirata MH, Hirata RDC. Peripheral blood mirome identified miR-155 as potential biomarker of MetS and cardiometabolic risk in obese patients [Internet]. International of Journal Molecular Sciences. 2021 ; 22 1-14 art. 1468.[citado 2024 jul. 03 ] Available from: https://doi.org/10.3390/ijms22031468
Vancouver
Cerda A, Amaral AA, Oliveira R de, Moraes TI, Braga AA, Saldarriaga MEG, Fajardo CM, Hirata TDC, Bonezi V, Salazar ABC, Dórea EL, Bernik MMS, Hirata MH, Hirata RDC. Peripheral blood mirome identified miR-155 as potential biomarker of MetS and cardiometabolic risk in obese patients [Internet]. International of Journal Molecular Sciences. 2021 ; 22 1-14 art. 1468.[citado 2024 jul. 03 ] Available from: https://doi.org/10.3390/ijms22031468
Artigo de periodico
Functional analysis of PCSK9 3'UTR variants and mRNA-miRNA interactions in patients with familial hypercholesterolemia (2021)
Los, Bruna ; Borges, Jéssica Bassani ; Oliveira, Victor Fernandes de ; Freitas, Renata Caroline Costa de ; Hernandez, Carolina Dagli ; Bortolin, Raul Hernandes ; Gonçalves, Rodrigo M ; Faludi, André Arpad ; Rodrigues, Alice Cristina ; Bastos, Gisele Medeiros ; Jannes, Cinthia Elim ; Pereira , Alexandre C ; Hirata, Rosario Dominguez Crespo ; Hirata, Mario Hiroyuki
Fonte: Epigenomics. Unidades: IDPC, ICB, FCF
Assuntos: HIPERCOLESTEROLEMIA, MICRORNAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LOS, Bruna et al. Functional analysis of PCSK9 3'UTR variants and mRNA-miRNA interactions in patients with familial hypercholesterolemia. Epigenomics, v. 13, n. 10, p. 779–791, 2021Tradução . . Disponível em: https://doi.org/10.2217/epi-2020-0462. Acesso em: 03 jul. 2024.
APA
Los, B., Borges, J. B., Oliveira, V. F. de, Freitas, R. C. C. de, Hernandez, C. D., Bortolin, R. H., et al. (2021). Functional analysis of PCSK9 3'UTR variants and mRNA-miRNA interactions in patients with familial hypercholesterolemia. Epigenomics, 13( 10), 779–791. doi:10.2217/epi-2020-0462
NLM
Los B, Borges JB, Oliveira VF de, Freitas RCC de, Hernandez CD, Bortolin RH, Gonçalves RM, Faludi AA, Rodrigues AC, Bastos GM, Jannes CE, Pereira AC, Hirata RDC, Hirata MH. Functional analysis of PCSK9 3'UTR variants and mRNA-miRNA interactions in patients with familial hypercholesterolemia [Internet]. Epigenomics. 2021 ; 13( 10): 779–791.[citado 2024 jul. 03 ] Available from: https://doi.org/10.2217/epi-2020-0462
Vancouver
Los B, Borges JB, Oliveira VF de, Freitas RCC de, Hernandez CD, Bortolin RH, Gonçalves RM, Faludi AA, Rodrigues AC, Bastos GM, Jannes CE, Pereira AC, Hirata RDC, Hirata MH. Functional analysis of PCSK9 3'UTR variants and mRNA-miRNA interactions in patients with familial hypercholesterolemia [Internet]. Epigenomics. 2021 ; 13( 10): 779–791.[citado 2024 jul. 03 ] Available from: https://doi.org/10.2217/epi-2020-0462
Artigo de periodico
Effect of statins on lipid metabolism-related microRNA expression in HepG2 cells (2021)
Cerda, Alvaro ; Bortolin, Raul Hernandes ; Manriquez, Victor; Salazar, Luis A ; Zambrano, Tomás ; Fajardo, Cristina Moreno ; Hirata, Mario Hiroyuki ; Hirata, Rosario Dominguez Crespo
Fonte: Pharmacological Reports. Unidade: FCF
Assuntos: MICRORNAS, LIPÍDEOS, MICRORNAS, EXPRESSÃO GÊNICA, ESTATINAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CERDA, Alvaro et al. Effect of statins on lipid metabolism-related microRNA expression in HepG2 cells. Pharmacological Reports, v. 73, p. 1-13 art. 868–880, 2021Tradução . . Disponível em: https://doi.org/10.1007/s43440-021-00241-3. Acesso em: 03 jul. 2024.
APA
Cerda, A., Bortolin, R. H., Manriquez, V., Salazar, L. A., Zambrano, T., Fajardo, C. M., et al. (2021). Effect of statins on lipid metabolism-related microRNA expression in HepG2 cells. Pharmacological Reports, 73, 1-13 art. 868–880. doi:10.1007/s43440-021-00241-3
NLM
Cerda A, Bortolin RH, Manriquez V, Salazar LA, Zambrano T, Fajardo CM, Hirata MH, Hirata RDC. Effect of statins on lipid metabolism-related microRNA expression in HepG2 cells [Internet]. Pharmacological Reports. 2021 ; 73 1-13 art. 868–880.[citado 2024 jul. 03 ] Available from: https://doi.org/10.1007/s43440-021-00241-3
Vancouver
Cerda A, Bortolin RH, Manriquez V, Salazar LA, Zambrano T, Fajardo CM, Hirata MH, Hirata RDC. Effect of statins on lipid metabolism-related microRNA expression in HepG2 cells [Internet]. Pharmacological Reports. 2021 ; 73 1-13 art. 868–880.[citado 2024 jul. 03 ] Available from: https://doi.org/10.1007/s43440-021-00241-3
Trabalho de evento
Proposta de medicina personalizada utilizando perfil farmacogenético em pacientes idosos usuários de varfarina (2021)
Rodrigues, Vitor Pitta; Araujo, Neire Niara Ferreira de; Bastos, Gisele Medeiros ; Hernandez, Carolina Dagli ; Hirata, Rosario Dominguez Crespo ; Hirata, Mario Hiroyuki
Fonte: Posters. Nome do evento: Reunião Anual da SBPC (Virtual). Unidade: FCF
Assuntos: ANTICOAGULANTES, POLIMORFISMO, GENÉTICA, FARMACOGENÉTICA, IDOSOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RODRIGUES, Vitor Pitta et al. Proposta de medicina personalizada utilizando perfil farmacogenético em pacientes idosos usuários de varfarina. 2021, Anais.. São Paulo: SBPC, 2021. Disponível em: https://reunioes.sbpcnet.org.br/73RA/inscritos/resumos/10242_1f340f1b1f65b6df5b5e3f94d95b11daf.pdf. Acesso em: 03 jul. 2024.
APA
Rodrigues, V. P., Araujo, N. N. F. de, Bastos, G. M., Hernandez, C. D., Hirata, R. D. C., & Hirata, M. H. (2021). Proposta de medicina personalizada utilizando perfil farmacogenético em pacientes idosos usuários de varfarina. In Posters. São Paulo: SBPC. Recuperado de https://reunioes.sbpcnet.org.br/73RA/inscritos/resumos/10242_1f340f1b1f65b6df5b5e3f94d95b11daf.pdf
NLM
Rodrigues VP, Araujo NNF de, Bastos GM, Hernandez CD, Hirata RDC, Hirata MH. Proposta de medicina personalizada utilizando perfil farmacogenético em pacientes idosos usuários de varfarina [Internet]. Posters. 2021 ;[citado 2024 jul. 03 ] Available from: https://reunioes.sbpcnet.org.br/73RA/inscritos/resumos/10242_1f340f1b1f65b6df5b5e3f94d95b11daf.pdf
Vancouver
Rodrigues VP, Araujo NNF de, Bastos GM, Hernandez CD, Hirata RDC, Hirata MH. Proposta de medicina personalizada utilizando perfil farmacogenético em pacientes idosos usuários de varfarina [Internet]. Posters. 2021 ;[citado 2024 jul. 03 ] Available from: https://reunioes.sbpcnet.org.br/73RA/inscritos/resumos/10242_1f340f1b1f65b6df5b5e3f94d95b11daf.pdf
Artigo de periodico
Circulating extracellular vesicles as biomarkers and drug delivery vehicles in cardiovascular diseases (2021)
Freitas, Renata Caroline Costa de ; Hirata, Rosario Dominguez Crespo ; Hirata, Mario Hiroyuki ; Aikawa, Elena
Fonte: Biomolecules. Unidade: FCF
Assuntos: BIOMARCADORES, PROTEÍNAS, LIPÍDEOS, DOENÇAS CARDIOVASCULARES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FREITAS, Renata Caroline Costa de et al. Circulating extracellular vesicles as biomarkers and drug delivery vehicles in cardiovascular diseases. Biomolecules, v. 11, p. 1-21 art. 388, 2021Tradução . . Disponível em: https://doi.org/10.3390/biom11030388. Acesso em: 03 jul. 2024.
APA
Freitas, R. C. C. de, Hirata, R. D. C., Hirata, M. H., & Aikawa, E. (2021). Circulating extracellular vesicles as biomarkers and drug delivery vehicles in cardiovascular diseases. Biomolecules, 11, 1-21 art. 388. doi:10.3390/biom11030388
NLM
Freitas RCC de, Hirata RDC, Hirata MH, Aikawa E. Circulating extracellular vesicles as biomarkers and drug delivery vehicles in cardiovascular diseases [Internet]. Biomolecules. 2021 ; 11 1-21 art. 388.[citado 2024 jul. 03 ] Available from: https://doi.org/10.3390/biom11030388
Vancouver
Freitas RCC de, Hirata RDC, Hirata MH, Aikawa E. Circulating extracellular vesicles as biomarkers and drug delivery vehicles in cardiovascular diseases [Internet]. Biomolecules. 2021 ; 11 1-21 art. 388.[citado 2024 jul. 03 ] Available from: https://doi.org/10.3390/biom11030388
Artigo de periodico
Functional analysis of PCSK9 3′UTR variants and mRNA–miRNA interactions in patients with familial hypercholesterolemia (2021)
Los, Bruna ; Borges, Jéssica Bassani ; Oliveira, Victor Fernandes de ; Freitas, Renata Carolina Costa de ; Hernandez, Carolina Dagli ; Bortolin, Raul Hernandes ; Gonçalves, Rodrigo M. ; Faludi, André A. ; Bastos, Gisele M. ; Jannes, Cinthia E. ; Pereira, Alexandre C. ; Rodrigues, Alice Cristina ; Hirata, Rosario Dominguez Crespo ; Hirata, Mario Hiroyuki
Fonte: Epigenomics. Unidades: ICB, FCF
Assuntos: FARMACOLOGIA, HIPERCOLESTEROLEMIA, VARIAÇÃO GENÉTICA, MICRORNAS, ENVELHECIMENTO, RNA MENSAGEIRO, EPIGÊNESE GENÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LOS, Bruna et al. Functional analysis of PCSK9 3′UTR variants and mRNA–miRNA interactions in patients with familial hypercholesterolemia. Epigenomics, v. 13, n. 10, p. 779–791, 2021Tradução . . Disponível em: https://doi.org/10.2217/epi-2020-0462. Acesso em: 03 jul. 2024.
APA
Los, B., Borges, J. B., Oliveira, V. F. de, Freitas, R. C. C. de, Hernandez, C. D., Bortolin, R. H., et al. (2021). Functional analysis of PCSK9 3′UTR variants and mRNA–miRNA interactions in patients with familial hypercholesterolemia. Epigenomics, 13( 10), 779–791. doi:10.2217/epi-2020-0462
NLM
Los B, Borges JB, Oliveira VF de, Freitas RCC de, Hernandez CD, Bortolin RH, Gonçalves RM, Faludi AA, Bastos GM, Jannes CE, Pereira AC, Rodrigues AC, Hirata RDC, Hirata MH. Functional analysis of PCSK9 3′UTR variants and mRNA–miRNA interactions in patients with familial hypercholesterolemia [Internet]. Epigenomics. 2021 ; 13( 10): 779–791.[citado 2024 jul. 03 ] Available from: https://doi.org/10.2217/epi-2020-0462
Vancouver
Los B, Borges JB, Oliveira VF de, Freitas RCC de, Hernandez CD, Bortolin RH, Gonçalves RM, Faludi AA, Bastos GM, Jannes CE, Pereira AC, Rodrigues AC, Hirata RDC, Hirata MH. Functional analysis of PCSK9 3′UTR variants and mRNA–miRNA interactions in patients with familial hypercholesterolemia [Internet]. Epigenomics. 2021 ; 13( 10): 779–791.[citado 2024 jul. 03 ] Available from: https://doi.org/10.2217/epi-2020-0462
Artigo de periodico
High serum miR-421 is associated with metabolic dysregulation and inflammation in patients with metabolic syndrome (2021)
Braga, Aécio Assunção ; Bortolin, Raul Hernandes ; Saldarriaga, Magda Elizabeth Graciano ; Hirata, Thiago Dominguez Crespo ; Cerda, Alvaro; Freitas, Renata Caroline Costa de ; Wang, Hui Tzu Lin ; Borges, Jessica B; França, Joao Italo Dias ; Masi, Laureane Nunes ; Curi, Rui ; Curi, Tania Cristina Phiton ; Sampaio, Marcelo Ferraz; Castro, Lara R; Bastos, Gisele Medeiros ; Hirata, Rosario Dominguez Crespo ; Hirata, Mario Hiroyuki
Fonte: Epigenomics. Unidade: FCF
Assuntos: ADIPOSIDADE, SÍNDROME X METABÓLICA, BIOMARCADORES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BRAGA, Aécio Assunção et al. High serum miR-421 is associated with metabolic dysregulation and inflammation in patients with metabolic syndrome. Epigenomics, v. 13, n. 6 p. 423–436, 2021Tradução . . Disponível em: https://doi.org/10.2217/epi-2020-0247. Acesso em: 03 jul. 2024.
APA
Braga, A. A., Bortolin, R. H., Saldarriaga, M. E. G., Hirata, T. D. C., Cerda, A., Freitas, R. C. C. de, et al. (2021). High serum miR-421 is associated with metabolic dysregulation and inflammation in patients with metabolic syndrome. Epigenomics, 13( 6 p. 423–436). doi:10.2217/epi-2020-0247
NLM
Braga AA, Bortolin RH, Saldarriaga MEG, Hirata TDC, Cerda A, Freitas RCC de, Wang HTL, Borges JB, França JID, Masi LN, Curi R, Curi TCP, Sampaio MF, Castro LR, Bastos GM, Hirata RDC, Hirata MH. High serum miR-421 is associated with metabolic dysregulation and inflammation in patients with metabolic syndrome [Internet]. Epigenomics. 2021 ; 13( 6 p. 423–436):[citado 2024 jul. 03 ] Available from: https://doi.org/10.2217/epi-2020-0247
Vancouver
Braga AA, Bortolin RH, Saldarriaga MEG, Hirata TDC, Cerda A, Freitas RCC de, Wang HTL, Borges JB, França JID, Masi LN, Curi R, Curi TCP, Sampaio MF, Castro LR, Bastos GM, Hirata RDC, Hirata MH. High serum miR-421 is associated with metabolic dysregulation and inflammation in patients with metabolic syndrome [Internet]. Epigenomics. 2021 ; 13( 6 p. 423–436):[citado 2024 jul. 03 ] Available from: https://doi.org/10.2217/epi-2020-0247
Artigo de periodico
Differentially expressed urinary exo-miRs and clinical outcomes in kidney recipients on short-term tacrolimus therapy: a pilot study (2020)
Freitas, Renata Caroline Costa de ; Bortolin, Raul Hernandes ; Genvigir, Fabiana Dalla Vecchia ; Bonezi, Vivian; Hirata, Thiago Dominguez Crespo ; Felipe, Claudia Rosso ; Silva Junior, Helio Tedesco ; Pestana, José Osmar Medina ; Cerda, Alvaro ; Doi, Sonia Quateli; Hirata, Mario Hiroyuki ; Hirata, Rosario Dominguez Crespo
Fonte: Epigenomics. Unidade: FCF
Assuntos: TRANSPLANTE DE RIM, MICRORNAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FREITAS, Renata Caroline Costa de et al. Differentially expressed urinary exo-miRs and clinical outcomes in kidney recipients on short-term tacrolimus therapy: a pilot study. Epigenomics, v. 12, n. 22, p. 2019-2034, 2020Tradução . . Disponível em: https://doi.org/10.2217/epi-2020-0160. Acesso em: 03 jul. 2024.
APA
Freitas, R. C. C. de, Bortolin, R. H., Genvigir, F. D. V., Bonezi, V., Hirata, T. D. C., Felipe, C. R., et al. (2020). Differentially expressed urinary exo-miRs and clinical outcomes in kidney recipients on short-term tacrolimus therapy: a pilot study. Epigenomics, 12( 22), 2019-2034. doi:10.2217/epi-2020-0160
NLM
Freitas RCC de, Bortolin RH, Genvigir FDV, Bonezi V, Hirata TDC, Felipe CR, Silva Junior HT, Pestana JOM, Cerda A, Doi SQ, Hirata MH, Hirata RDC. Differentially expressed urinary exo-miRs and clinical outcomes in kidney recipients on short-term tacrolimus therapy: a pilot study [Internet]. Epigenomics. 2020 ; 12( 22): 2019-2034.[citado 2024 jul. 03 ] Available from: https://doi.org/10.2217/epi-2020-0160
Vancouver
Freitas RCC de, Bortolin RH, Genvigir FDV, Bonezi V, Hirata TDC, Felipe CR, Silva Junior HT, Pestana JOM, Cerda A, Doi SQ, Hirata MH, Hirata RDC. Differentially expressed urinary exo-miRs and clinical outcomes in kidney recipients on short-term tacrolimus therapy: a pilot study [Internet]. Epigenomics. 2020 ; 12( 22): 2019-2034.[citado 2024 jul. 03 ] Available from: https://doi.org/10.2217/epi-2020-0160
Artigo de periodico
CYP3A5*3 and CYP2C8*3 variants influence exposure and clinical outcomes of tacrolimus-based therapy (2020)
Genvigir, Fabiana Dalla Vecchia; Campos-Salazar, Antony Brayan ; Felipe, Claudia Rosso ; Silva Junior, Helio Tedesco ; Pestana, José Osmar Medina ; Doi, Sonia de Quateli; Cerda, Alvaro; Hirata, Mario Hiroyuki ; Herrero, María José; Hirata, Rosario Dominguez Crespo
Fonte: Pharmacogenomics. Unidade: FCF
Assuntos: TRANSPLANTE DE RIM, FARMACOCINÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GENVIGIR, Fabiana Dalla Vecchia et al. CYP3A5*3 and CYP2C8*3 variants influence exposure and clinical outcomes of tacrolimus-based therapy. Pharmacogenomics, v. 21, n. 1, p. 7-21, 2020Tradução . . Disponível em: https://doi.org/10.2217/pgs-2019-0120. Acesso em: 03 jul. 2024.
APA
Genvigir, F. D. V., Campos-Salazar, A. B., Felipe, C. R., Silva Junior, H. T., Pestana, J. O. M., Doi, S. de Q., et al. (2020). CYP3A5*3 and CYP2C8*3 variants influence exposure and clinical outcomes of tacrolimus-based therapy. Pharmacogenomics, 21( 1), 7-21. doi:10.2217/pgs-2019-0120
NLM
Genvigir FDV, Campos-Salazar AB, Felipe CR, Silva Junior HT, Pestana JOM, Doi S de Q, Cerda A, Hirata MH, Herrero MJ, Hirata RDC. CYP3A5*3 and CYP2C8*3 variants influence exposure and clinical outcomes of tacrolimus-based therapy [Internet]. Pharmacogenomics. 2020 ; 21( 1): 7-21.[citado 2024 jul. 03 ] Available from: https://doi.org/10.2217/pgs-2019-0120
Vancouver
Genvigir FDV, Campos-Salazar AB, Felipe CR, Silva Junior HT, Pestana JOM, Doi S de Q, Cerda A, Hirata MH, Herrero MJ, Hirata RDC. CYP3A5*3 and CYP2C8*3 variants influence exposure and clinical outcomes of tacrolimus-based therapy [Internet]. Pharmacogenomics. 2020 ; 21( 1): 7-21.[citado 2024 jul. 03 ] Available from: https://doi.org/10.2217/pgs-2019-0120

Unidades USP

ReP

Filtros

Tipo de material

Unidades USP

Departamento

Autores

Autores USP

Ano de publicação

Assuntos

Título da fonte

Editora

Nome do evento

País de publicação

Grupo de pesquisa

Agência de fomento

Indexado em

Afiliação dos autores externos normalizada

Afiliação dos autores externos não normalizada

País das instituições de afiliação dos autores externos